DIA: Compliance Standards for Active Pharmaceutical Ingredients

The Drug Information Association (DIA), in collaboration with the World Health Organization (WHO) and the European Directorate for the Quality of Medicines & HealthCare (EDQM), will host the Quality of Active Pharmaceutical Ingredients Conference from September 5-7, 2009 in Hyderabad, India.

This conference will focus on the current regulatory requirements for the quality of Active Pharmaceutical Ingredients and compliance with Good Manufacturing Practice (GMP) standards from a global regulatory authority perspective. Sessions will include:

· Regulatory Requirements with Relevance for Quality of Active Pharmaceutical Ingredients

· Compliance of Active Pharmaceutical Ingredients Manufacturers with GMP Standards

· Current Issues and Challenges in the Development of Pharmacopoeial Monographs

· Active Pharmaceutical Ingredients Certification and WHO Prequalification

“One of the features of this conference will be a discussion of the recent bilateral confidentiality agreements regarding the exchange of information related to active pharmaceutical ingredients and excipients used in the manufacture of medicinal products,” explains program co-chair Dr Susanne Keitel, director, EDQM.

Dr Khanna, executive director, Science & Technology, Jubilant Organosys, and S Srinvasan, CEO and MD, Matrix Laboratories will deliver the joint keynote address.